Gianna Melillo

Results of an e-diary study compare symptoms of perimenstrual and nonperimenstrual migraine attacks among women.

The fallout from COVID-19 has spotlighted the limitations of US mental health care, prompting the question if alternative treatments—like psychedelics—could help address current and impending crises.

Results of a Swedish retrospective cohort study showed reduced rates of type 1 diabetes-related amputations over the past 2 decades.

Results of a cross-sectional study highlight the clinical features shared by bipolar disorder and migraine, and assesses characteristics of patients with both conditions.

In a panel at the 5th annual Heart in Diabetes Conference, John McMurray, MD, and Javed Butler, MD, highlighted recent pharmacological developments in heart failure (HF) and offered insights on overlooked areas in the field.

A session at the 5th annual Heart in Diabetes Conference highlights the long-term risks of gestational diabetes.

New research presented at the 5th Heart in Diabetes Conference highlights potential therapeutic options for patients with COVID-19 and diabetes.

Results of a large retrospective cohort study showed veterans with chronic headache are at an increased risk of suicide attempts compared with those experiencing other forms of chronic pain.

In part 2 of a 2-part series, we look at the mental health risks affecting 9/11 rescuers, the lessons learned that apply to health care workers during the current pandemic, as well as continued barriers to care.

Results of an Australian study highlight the changes that occur in the gut microbiome of pregnant patients with type 1 diabetes.

Results of a data analysis found once-daily zanubrutinib dosing in patients with mantle cell lymphoma (MCL) is safe and effective.

A case report details the presentation of systemic lupus erythematous in a young, previously healthy individual.

David McIntyre, MD, FRACP, describes lessons learned from the pandemic for ensuring appropriate continuation of care for pregnant patients with diabetes.

Aleksandar Kostic, PhD, an assistant professor of microbiology at Harvard Medical School, outlines what needs to happen next in his research developing a type 1 diabetes (T1D) vaccine.

Although rates of sleep disorders among pediatric migraineurs appear to be high, these conditions largely go undiagnosed, according to recently published study findings.

New CDC data show an increase in some health care–associated infections during COVID-19.

Research shows how socioeconomic status can affect prognosis among patients with hepatocellular carcinoma (HCC).

Findings of a recent review highlight the potential role nutrition can play in pediatric migraine.

Findings indicate that youth with type 1 diabetes may benefit from limiting fat intake.

Results of a multicenter study showed 43% of patients with advanced melanoma treated with anti–programmed cell death 1 therapy experienced chronic complications.

Researchers characterized new-onset headache, migraine, and tension-type headache (TTH) among patients with confirmed cases of COVID-19.

Results of a score-matched analysis showed individuals with hepatocellular cancer reported poor mental health as time progressed after diagnosis.

Research shows higher levels of interleukin 6 in patients with chronic coronary syndrome were associated with an increased risk of cardiovascular events in patients with chronic kidney disease.

Researchers offer recommendations for addressing polypharmacy and potentially inappropriate medication (PIM) use among older patients with cancer.

The United States Preventive Services Task Force (USPSTF) lowered its recommended screening age for type 2 diabetes and prediabetes from 40 to 35 years among overweight and obese individuals.

Post hoc analyses revealed patients with episodic migraine (EM) who take erenumab experience less intense headache pain on average.

Ann Goebel-Fabbri, PhD, a clinical psychologist in Boston, Massachusettes, dispels common misconceptions involving eating disorders among patients with type 1 diabetes.

New study findings indicate individuals genetically predisposed to insomnia have a higher chance of suffering from migraine.

Pfizer's COVID-19 vaccine has gained full approval from the FDA.

Researchers revealed exposure to air pollution increases the risk of severe hypoglycemic episodes among youth with type 1 diabetes (T1D) in Germany.